These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745 [TBL] [Abstract][Full Text] [Related]
9. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia. Cohanim M; DeLuca HF; Yendt ER Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527 [No Abstract] [Full Text] [Related]
10. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol. Arora N; Sandroni S; Moles K Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854 [TBL] [Abstract][Full Text] [Related]
14. Renal hypophosphatemic rickets. Growth and mineral metabolism after treatment with calcitriol (1,25-dihydroxyvitamin D3) and phosphate supplementation. Tsuru N; Chan JC; Chinchilli VM Am J Dis Child; 1987 Jan; 141(1):108-10. PubMed ID: 3788870 [TBL] [Abstract][Full Text] [Related]
15. Growth and bone mineral density in a child with X-linked hypophosphatemic rickets: early response to treatment. Sugiyama T; Tanaka H; Kawai S J Bone Miner Metab; 1999; 17(2):137-40. PubMed ID: 10340642 [No Abstract] [Full Text] [Related]
17. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. Saggese G; Baroncelli GI; Bertelloni S; Perri G J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269 [TBL] [Abstract][Full Text] [Related]
18. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749 [No Abstract] [Full Text] [Related]
19. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH). Roof BS; Piel CF; Gordan GS Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621 [No Abstract] [Full Text] [Related]
20. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure. Chan JC; Kodroff MB; Landwehr DM Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]